Initial combination therapy with olmesartan/hydrochlorothiazide in moderate-to-severe hypertension. 2006

L C Rump, and E Ambrosioni, and M Burnier, and W Hörl, and A J Rabelink

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004232 Diuretics Agents that promote the excretion of urine through their effects on kidney function. Diuretic,Diuretic Effect,Diuretic Effects,Effect, Diuretic,Effects, Diuretic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

L C Rump, and E Ambrosioni, and M Burnier, and W Hörl, and A J Rabelink
July 1994, European heart journal,
L C Rump, and E Ambrosioni, and M Burnier, and W Hörl, and A J Rabelink
February 2012, Current medical research and opinion,
L C Rump, and E Ambrosioni, and M Burnier, and W Hörl, and A J Rabelink
December 1987, Journal of clinical hypertension,
L C Rump, and E Ambrosioni, and M Burnier, and W Hörl, and A J Rabelink
January 2008, Drugs,
L C Rump, and E Ambrosioni, and M Burnier, and W Hörl, and A J Rabelink
January 2008, Vascular health and risk management,
L C Rump, and E Ambrosioni, and M Burnier, and W Hörl, and A J Rabelink
May 2009, Journal of clinical hypertension (Greenwich, Conn.),
L C Rump, and E Ambrosioni, and M Burnier, and W Hörl, and A J Rabelink
January 2011, Drugs,
L C Rump, and E Ambrosioni, and M Burnier, and W Hörl, and A J Rabelink
July 1995, Journal of cardiovascular pharmacology,
L C Rump, and E Ambrosioni, and M Burnier, and W Hörl, and A J Rabelink
January 2009, Drugs,
L C Rump, and E Ambrosioni, and M Burnier, and W Hörl, and A J Rabelink
September 1985, Journal of clinical pharmacology,
Copied contents to your clipboard!